Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Sales | 298,978 | 296,846 | 254,755 | 179,331 | 200,204 |
| Cost of Goods | 109,980 | 132,758 | 140,798 | 96,917 | 72,101 |
| Gross Profit | 188,998 | 164,088 | 113,957 | 82,414 | 128,103 |
| Operating Expenses | 89,982 | 85,232 | 94,972 | 205,763 | 55,992 |
| Operating Income | 99,996 | 79,614 | 19,783 | -122,432 | 72,212 |
| Interest Expense | 6,960 | 7,718 | 7,642 | 11,335 | 2,539 |
| Other Income | 16,239 | 31,257 | -2,962 | 98,635 | 85,560 |
| Pre-tax Income | 109,275 | 103,153 | 9,179 | -35,132 | 155,233 |
| Income Tax | 43,030 | 40,697 | 11,090 | 31,190 | 58,428 |
| Net Income Continuous | 66,245 | 62,456 | -1,911 | -66,322 | 96,805 |
| Net Income Extraordinary | N/A | N/A | N/A | -1,216 | N/A |
| Net Income | $66,245 | $62,456 | $-1,911 | $-67,538 | $96,805 |
| EPS Basic Total Ops | 0.63 | 0.59 | -0.07 | -0.66 | 0.97 |
| EPS Basic Continuous Ops | 0.63 | 0.59 | -0.08 | -0.65 | 0.97 |
| EPS Diluted Total Ops | 0.61 | 0.58 | -0.07 | -0.66 | 0.96 |
| EPS Diluted Continuous Ops | 0.61 | 0.58 | -0.07 | -0.65 | 0.96 |
| EBITDA(a) | $127,011 | $105,606 | $42,304 | $-97,741 | $84,686 |